AT&T, Inc. (NYSE:T) is slated to report its second-quarter 2014 financial results on Jul 23, after the market closes. In the last reported quarter, the company had delivered a 1.43% earnings surprise. Let’s see how things are shaping up prior to this announcement. AT&T Inc. (NYSE:T) stock performance was -0.58% in last session and finished…
Nokia Corporation (ADR) (NYSE:NOK) smartphones have long been known for their fantastic snappers, and the Lumia range has included some fantastic photo-taking opportunities, with the Nokia Lumia 1020 having been the very top of the range with a rear-facing camera that packed 41 megapixels. Nokia Corporation (ADR) (NYSE:NOK) stock performance was -1.42% in last session…
Smartphone maker BlackBerry Ltd (NASDAQ:BBRY) sold most of its Canadian real estate — more than 3 million square feet — earlier this year for $278 million. Last Thursday the company announced that it has agreed to sell an R&D facility in Germany to Volkswagen for an undisclosed sum. BlackBerry Ltd (NASDAQ:BBRY) stock performance was -0.47%…
Here is a selection of telecom stocks to watch on the markets today. In the news, a lot of European leaders in telecoms such as Telefonica in Spain, Telecom Italia in Italy, Vodafone Group Plc in the UK, Deutsche Telekom in Germany, but also Verizon Communications Inc. (NYSE:VZ), in the USA. Spain’s Telefonica S.A. (ADR)…
Finnish telecom company Nokia Corporation (ADR) (NYSE:NOK) today elected India-origin Vivek Badrinath among new members of its board whose term will end with next annual general meeting in 2015. Nokia Corporation (ADR) (NYSE:NOK) stock performance was 0.75% in last session and finished the day at $8.04. Traded volume was 15.64million shares in the last session…
Teva Pharmaceutical Industries Ltd. (ADR) (NYSE:TEVA) announced that the U.S. Court of Appeals for the Federal Circuit today upheld a ruling by the U.S. District Court for the District of Delaware finding Bristol-Myers Squibb’s entecavir compound claim of U.S. Patent No. 5,206,244 invalid. Teva’s ANDA for entecavir has received tentative approval from the U.S. Food…
